Fiji is facing a significant potential HIV crisis among individuals who inject drugs, with projections indicating that the number of infections could soar to 25,000 by 2029 if immediate action is not undertaken, according to a recent rapid assessment by the World Health Organization (WHO).
The report identifies several key factors contributing to the epidemic, including high-risk injecting practices, insufficient access to sterile equipment, a lack of awareness around HIV and hepatitis risks, and pervasive stigma surrounding the issue. In particular, the increasing use of crystal methamphetamine is concerning, as many users are reportedly transitioning to injecting shortly after they start using the drug.
The report warns that without prompt intervention, HIV prevalence in Fiji could escalate significantly. The high mobility within the Pacific region raises concerns that similar outbreaks could emerge in neighboring island nations, significantly threatening public health across the area.
In light of these challenges, health workers, religious leaders, and those who inject drugs are calling for immediate, evidence-based, and culturally relevant responses to the crisis. WHO experts have highlighted the crucial need to expand harm reduction programs, HIV testing, and treatment services to mitigate the epidemic and safeguard both national and regional health.
The assessment also emphasizes that no individual island nation can ensure its health security unless all islands work proactively to enhance their HIV prevention, diagnosis, treatment, and surveillance systems. A collaborative regional approach is vital for fostering resilience against public health threats.
WHO’s findings indicate a significant unmet need for services, coupled with robust support for compassionate, evidence-based interventions. Many stakeholders have voiced the necessity for urgent, public health-focused actions to combat the crisis. To directly address the rising infection rates, the WHO recommends implementing measures such as the distribution of free, low-threshold sterile needles and syringes through various community channels, including pharmacies and peer support networks.
The call to action represents an opportunity for Fiji not only to confront the immediate public health challenge but also to pave the way for enhanced health security across the region.